Predictors for non-adherence to antiretroviral therapy

Sexual Health

Volumn 1, Issue 4, 2004, Pages 251-257

  Wilson, K J ^a   Doxanakis, A ^a   Fairley, C K ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

Author keywords

Adherence; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DEPRESSION; DRINKING BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; MALE; PATIENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK; SELF CONCEPT; SOCIAL SUPPORT; STATISTICS;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEPRESSION; HIV INFECTIONS; HUMANS; LIFE STYLE; MALE; ODDS RATIO; PATIENT COMPLIANCE; PATIENT DROPOUTS; QUESTIONNAIRES; SELF EFFICACY; SOCIAL SUPPORT; VICTORIA;

EID: 25144435813     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH04020     Document Type: Article

References (29)

1. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antitetroviral-niave HIV-1 infected adults. AIDS 2001; 15(11): 1369-77. doi: 10.1097/00002030-200107270- 00006
2. Correll PK, Law MG, McDonald AM, Cooper DA, Kaldor JM. HIV disease progression in Australia in the time of combination antiretroviral therapies. Med J Aust 1998; 169(9): 469-72.
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998; 338(13): 853-60.
4. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagner MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133(1): 21-30.
5. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998; 279(24): 1997-83.
6. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, Montefiori DC, O'Connor DH, Davis BT, Lee PK, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. [Comment] Nature 2002; 420(6914): 434-9.
7. Chesney M, Ickovics J. 'ACTG adherence baseline questionnaire.' San Francisco: AIDS Clinical Trials Group (ACTG) Recruitment, Adherence and Retention Subcommittee; 1997.
8. Molassiotis A, Nahas Lopez V, Chung WY, Chung WYR, Lam SWC, Li CKP, et al. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS 2002; 13(5): 301-10.
9. Duong M, Piroth L, Grappin M, et al. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. HIV Clin Trials 2001; 2(2): 128-35.
10. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med 2002; 54(10): 1481-96.
11. Fairley C, Levy D, Rayner C, et al. Randomised trial of an adherence program for clients with HIV Int J STD AIDS 2003; 14(12): 891-5.
12. US Department of Health and Human Services/Public Health Service/Centers for Disease Control and Prevention/National Center for HIV, STD and TB Prevention. HIV/AIDS surveillance report. US HIV and AIDS cases reported through December 2001. End Year Edition Vol. 13, No. 2.
13. National Centre for HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2002. Sydney: National Centre for HIV Epidemiology and Clinical Research, The University of New South Wales; 2002.
14. Scott M. Lifestyle checklist. Sydney, Australia: Australian Society for HIV Medicine (ASHM); 1998.
15. American Health Consultants. I. Medications adherence checklist. Aids Alert 2001; 16(7): 2S1.
16. Radioff L. The CES-D scale: a self-report depression scale for research in the general population. In: Applied psychological measurement. 1977. pp. 385-401.
17. HIV/AIDS Update. A glance at the HIV epidemic. In: Centres for Disease Control and Prevention, National Centre for HIV, STD and TB prevention.
18. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS 1999; 13(9): 1099-107.
19. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 2): S171-6.
20. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell-Cope GM, Inouye J, Henry SB, Nicholas PK, Portillo CJ. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999; 13(3): 185-97.
21. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 1999; 13(13): 1763-9.
22. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for sub optimal adherence to highly active antiretroviral therapy. J Acq Imm Def Syn 1999; 31: S136-9.
23. Weidle P, Ganea C, Ernst J, et al. Multiple reasons for non-adherence to antiretroviral medications in an inner-city minority population: need for a multi-faceted approach to improve adherence. In: 12th World AIDS Conference; June 1998; Geneva.
24. Stone VE, Adelson-Mitty J, Duefield C, et al. Adherence to protease inhibitor therapy in clinical practice: usefulness of demographics, attitudes and knowledge as predictors. In: 12th World AIDS Conference; June 1998; Geneva.
25. Hirschcorn L, Quinones J, Goldin S, et al. Highly active antiretroviral therapy in the 'real world': experiences in an inner-city community health center. In: 12th World AIDS Conference; June 1998; Geneva.
26. Bonafanti P, Pusteria L, Facetti O, et al. Adverse reactions during protease inhibitor therapy. In: 12th World AIDS Conference; June 1998; Geneva.
27. Wenger NS, Gifford AL, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral adherence. In: 6th Conference on Retroviruses and Opportunistic Infections; January 1999; Chicago.
28. Gebo KA, Keruly J, Moore RD. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. J Gen Intern Med 2003; 18: 104-11.
29. Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 2002; 16: 767-74.